PAM
SIOX

Panagora Asset Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Panagora Asset Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-90
Closed -$13K – 2355
2015
Q4 		$13K Buy
+90
New +$11.7K ﹤0.01% 2196

Other funds holding SIOX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Panagora Asset Management's SIOX Position: Q1 2016 in Review

Panagora Asset Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2016, closing a stake of 90 shares — an estimated $13K sold.

Panagora Asset Management first reported a position in SIOX in Q4 2015 and held it in 1 quarter. The position peaked at $13K in Q4 2015. 70 funds tracked by Wall St. Rank hold SIOX as of Q1 2016.

  • Panagora Asset Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Panagora Asset Management sold 90 Sio Gene Therapies Inc. Common Stock shares in Q1 2016, an estimated $13K.
  • Panagora Asset Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 1 quarter.
  • Panagora Asset Management's Sio Gene Therapies Inc. Common Stock position peaked at $13K in Q4 2015.
  • 70 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2016.

Based on Panagora Asset Management's 13F filing for Q1 2016, filed 16 May 2016.